Novel Approaches for Targeting Thymidylate Synthase To Overcome the Resistance and Toxicity of Anticancer Drugs

被引：46
|
作者：
Garg, Divita [1 ,2 ]
Henrich, Stefan [1 ]
Salo-Ahen, Outi M. H. [1 ,3 ]
Myllykallio, Hannu [4 ]
Costi, Maria P. [5 ]
Wade, Rebecca C. [1 ]
机构：
[1] Heidelberg Inst Theoret Studies gGmbH, Mol & Cellular Modeling Grp, Heidelberg, Germany
[2] Helmholtz Zentrum Munchen, Inst Biol Struct, Neuherberg, Germany
[3] Abo Akad Univ, Dept Biosci, Turku, Finland
[4] Ecole Polytech, CNRS, INSERM, Lab Opt & Biosci,UMR7645,U696, F-91128 Palaiseau, France
[5] Univ Modena & Reggio Emilia, Dipartimento Sci Farmaceut, Modena, Italy
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2010年 / 53卷 / 18期
关键词：
HISTONE DEACETYLASE INHIBITOR; ENHANCES 5-FLUOROURACIL CYTOTOXICITY; MESSENGER-RNA TRANSLATION; GENE-EXPRESSION; CELL-GROWTH; DIHYDROFOLATE-REDUCTASE; ANTITUMOR-ACTIVITY; DOWN-REGULATION; HUMAN LIVER; IN-VITRO;
D O I：
10.1021/jm901869w
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：6539 / 6549
页数：11
相关论文
共 50 条
  • [31] A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance
    Wang, Zhigang
    Xu, Zoufeng
    Zhu, Guangyu
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (50) : 15564 - 15568
  • [32] Characterization of New Potential Anticancer Drugs Designed To Overcome Glutathione Transferase Mediated Resistance
    Johansson, Katarina
    Ito, Mika
    Schophuizen, Carolien M. S.
    Thengumtharayil, Sherin Mathew
    Heuser, Vanina D.
    Zhang, Jie
    Shimoji, Miyuki
    Vahter, Marie
    Wee Han Ang
    Dyson, Paul J.
    Shibata, Aya
    Shuto, Satoshi
    Yoshihiro, Ito
    Abe, Hiroshi
    Morgenstern, Ralf
    MOLECULAR PHARMACEUTICS, 2011, 8 (05) : 1698 - 1708
  • [33] New drugs for breast cancer subtypes: Targeting driver pathways to overcome resistance
    Curigliano, Giuseppe
    CANCER TREATMENT REVIEWS, 2012, 38 (04) : 303 - 310
  • [34] Targeting cysteine residues of biomolecules: New approaches for the design of antiviral and anticancer drugs
    Scozzafava, A
    Casini, A
    Supuran, CT
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (12) : 1167 - 1185
  • [35] Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells
    Menendez, JA
    Vellon, L
    Lupu, R
    MEDICAL HYPOTHESES, 2005, 64 (05) : 997 - 1001
  • [36] BCL-2 MODULATION OF APOPTOSIS INDUCED BY ANTICANCER DRUGS - RESISTANCE TO THYMIDYLATE STRESS IS INDEPENDENT OF CLASSICAL RESISTANCE PATHWAYS
    FISHER, TC
    MILNER, AE
    GREGORY, CD
    JACKMAN, AL
    AHERNE, GW
    HARTLEY, JA
    DIVE, C
    HICKMAN, JA
    CANCER RESEARCH, 1993, 53 (14) : 3321 - 3326
  • [37] Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance
    Kapper, Celine
    Oppelt, Peter
    Arbeithuber, Barbara
    Gyunesh, Ayberk Alp
    Vilusic, Ivona
    Stelzl, Patrick
    Rezk-Fuereder, Marlene
    LIFE SCIENCES, 2024, 349
  • [38] Drugging Protein-Protein Interfaces of a Supramolecular Assembly as a Means to Overcome Resistance to Active Site Thymidylate Synthase Inhibitors
    Abramyan, Tigran M.
    Tropsha, Alexander
    Lee, Andrew L.
    Sapienza, Paul J.
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 515A - 515A
  • [39] Targeting the mechanisms of DNA damage response (DDR) to overcome anticancer drug resistance of tumor cells
    van Stuijvenberg, J.
    Fritz, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S78 - S78
  • [40] Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer
    Ren, Fang
    Shen, Jacson
    Shi, Huirong
    Hornicek, Francis J.
    Kan, Quancheng
    Duan, Zhenfeng
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2016, 1866 (02): : 266 - 275
12345